I

Icecure Medical Ltd
TASE:ICCM

Watchlist Manager
Icecure Medical Ltd
TASE:ICCM
Watchlist
Price: 425.9 ILS 0.12%
Market Cap: ₪193.3m

Operating Margin

-170.1%
Current
Declining
by 18.9%
vs 3-y average of -151.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-170.1%
=
Operating Income
$-16.3m
/
Revenue
$3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-170.1%
=
Operating Income
₪-16.3m
/
Revenue
$3m

Peer Comparison

Country Company Market Cap Operating
Margin
IL
Icecure Medical Ltd
TASE:ICCM
193.3m ILS
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.9B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.1B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.7B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.5B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Lower than 87% of companies in Israel
Percentile
13th
Based on 734 companies
13th percentile
-170.1%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

Icecure Medical Ltd
Glance View

Market Cap
193.3m ILS
Industry
Health Care

IceCure Medical Ltd. is a commercial stage medical device company, which engages in the research and development, design, manufacture, and marketing of cryoablation systems and technologies based on liquid nitrogen for the treatment of tumors. The firm develops and markets minimally invasive cryoablation therapies for women’s health and general oncology market. Icecure Medical Ltd’s proprietary IceSense3 and ProSense systems provide minimally invasive, in-office definitive treatment for symptomatic tumors in various organs. The procedure is done under ultrasound or Computed Tomography (CT) imaging to guide a small probe (thin hollow needle) into the tumor. The system then uses extremely cold temperatures to destroy (ablate) the targeted tumor in situ. Icecure Medical Ltd supports investigator-initiated studies at various academic institutions around the globe, including Kameda and Saint Johns.

ICCM Intrinsic Value
Not Available
I
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-170.1%
=
Operating Income
$-16.3m
/
Revenue
$3m
What is Icecure Medical Ltd's current Operating Margin?

The current Operating Margin for Icecure Medical Ltd is -170.1%, which is below its 3-year median of -151.2%.

How has Operating Margin changed over time?

Over the last 3 years, Icecure Medical Ltd’s Operating Margin has decreased from -36.9% to -170.1%. During this period, it reached a low of -167.4% on Sep 30, 2022 and a high of -30.1% on Mar 31, 2021.

Back to Top